Objective Assessment of Metabolic Monitoring in Patients Treated With Seroquel® or Seroquel® XR/Quetiapine Fumarate: Use of IMS Disease Analyzer to Assess Physician Behaviour in the UK and Germany
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 6,153
- 主要终点
- Counseling patients on healthy eating, exercise and healthy lifestyle improvements during patient encounters.
研究概览
简要总结
A study to evaluate the effectiveness of an update of educational materials with respect to evaluation of monitoring of metabolic parameters
详细描述
Objective assessment of metabolic monitoring in patients treated with Seroquel® or Seroquel® XR/quetiapine fumarate: use of IMS Disease Analyzer to assess physician behaviour in the UK and Germany
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Electronic medical records of patients with diagnoses of schizophrenia, Bipolar Disorder (BPD) or Major Depressive Disorder (MDD) treated with Seroquel® or Seroquel®XR during the calendar periods: 13 Feb - 31 Aug 2012 seen by GP & psychiatrists in Germany & 11 Jan-31 July 2012 seen by GPs in the UK
排除标准
- •Patients with above mentioned diagnoses treated with Seroquel® or Seroquel® XR/quetiapine fumarate not having any medical encounters during the time periods: 13 Feb - 31 Aug 2012 in Germany & 11 Jan-31 July 2012 by GPs in the UK
结局指标
主要结局
Counseling patients on healthy eating, exercise and healthy lifestyle improvements during patient encounters.
时间窗: Over 6 months following the distribution of metabolic educational materials in the country
Determination whether physicians in the UK and Germany perform monitoring of patients treated with Seroquel® and Seroquel® XR including measurement of the following during patient encounters: weight at drug initiation and over the course of treatment.
时间窗: Over 6 months following the distribution of metabolic educational materials in the country
Monitoring of hyperlipidemia during patient encounters.
时间窗: Over 6 months following the distribution of metabolic educational materials in the country
Monitoring for signs and symptoms of hyperglycemia during patient encounters.
时间窗: Over 6 months following the distribution of metabolic educational materials in the country
Monitoring of blood glucose in patients with diabetes; monitoring of patients with risk factors for diabetes for worsening of glycemic control during patient encounters.
时间窗: Over 6 months following the distribution of metabolic educational materials in the country
次要结局
未报告次要终点